Your CSV is on the way
We’ve sent your CSV file to [email protected]
Search Startups
Tagged as ('cancer') Startups
Filters
Clear
280 Startups
14 In the News
27 Recently Updated
I already have access,
-
Total Funding$6.37BRaised396Events
-
Private Funding$3.31BRaised263Rounds
-
Public Offerings$2.59BRaised114Offerings
-
M&A$473MRaised19Deals
Funding
Number of Employees
Rounds / Deals
Funding Stage
BioSight
Presumed Inactive
?
Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
Convergent R.N.R.
Pyxis Diagnostics
Lutris Pharma
TNIK Therapeutics
Presumed Inactive
?
Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
CuratioDL
ViruCure Therapeutics
Notifications settings
Off
Frequency:
Select all
Search Startups
Funding Amount
Funding Stages
-
Total Funding$6.37BRaised396Events
-
Private Funding$3.31BRaised263Rounds
-
Public Offerings$2.59BRaised114Offerings
-
M&A$473MRaised19Deals
Funding
Rounds / Deals
Raised
$62.5M
BioSight
Presumed Inactive
?
Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
Therapeutics for Oncology and Hematological Disorders
Founded:1999
Business Model:B2B
Employees:1-10
Funding Stage:Acquired
Raised
$3.7M
Convergent R.N.R.
X-ray Focusing for Cancer Treatment
Founded:2010
Business Model:B2B
Employees:11-50
Funding Stage:Mature
Raised
$1.2M
Pyxis Diagnostics
AI-powered Cancer Diagnostics Platform for Predicting Immuno-oncology Drug Response
Founded:2019
Business Model:B2B
Employees:11-50
Funding Stage:Seed
Raised
$10.69M
Lutris Pharma
Anticancer Therapy for Patients Treated with EGFR Inhibitors
Founded:2015
Business Model:B2B
Employees:1-10
Funding Stage:Seed
Raised
Undisclosed
TNIK Therapeutics
Presumed Inactive
?
Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
Small Molecule Inhibitors of TNIK
Founded:2018
Business Model:B2B
Employees:1-10
Funding Stage:Seed
Raised
$317K
CuratioDL
Deep-learning-based Cancer Management Solutions
Founded:2021
Business Model:B2B, B2B2C
Employees:1-10
Funding Stage:Seed
Raised
Undisclosed
ViruCure Therapeutics
Oncolytic Virus-based Technology Platform for Treating Cancer
Founded:2016
Business Model:B2B
Employees:1-10
Funding Stage:Seed
Unlock financial data
Finder is provided for free by the non-profit organization Startup Nation Central.
- Get unlimited search results
- Save to custom lists - Watchlists
- Get notified with news and updates
- Connect with people
And much more...
I already have access,